Taosheng Chen

7.7k citations

154 papers · 5.0k indexed · h-index 39

Molecular Biology top 5%
Pharmacology top 0.1%
Oncology top 2%
Endocrinology, Diabetes and Metabolism top 1%
Genetics top 2%

Co-authors: Wenwei Lin Sergio C. Chai William L. Farrar Lihua Wang Yueming Wang Peter Oladimeji Su Sien OngJing Wu
Topics: Pharmacogenetics and Drug Metabolism (59 papers)Hormonal Regulation and Hypertension (36 papers)Estrogen and related hormone effects (30 papers)
Cited by: Pharmacology Oncology Endocrinology, Diabetes and Metabolism
Journals: Science Cell Proceedings of the National Academy of Sciences
Partner nations: United States China United Kingdom

In The Last Decade

Taosheng Chen

149 papers receiving 4.9k citations

Peers

Countries citing papers authored by Taosheng Chen

Since Specialization

Citations

This map shows the geographic impact of Taosheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taosheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taosheng Chen more than expected).

Fields of papers citing papers by Taosheng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taosheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taosheng Chen. The network helps show where Taosheng Chen may publish in the future.

Co-authorship network of co-authors of Taosheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Taosheng Chen. A scholar is included among the top collaborators of Taosheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taosheng Chen. Taosheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decoding the selective chemical modulation of CYP3A4 2025 ·Nature Communications ·Jingheng Wang,Stanley Nithianantham,Sergio C. Chai,Kwan‐Young Jung,Lei Yang,Han Wee Ong,Yong Li,Yifan Zhang,Darcie J. Miller,Taosheng Chen	1
2	Direct targeting and regulation of RNA polymerase II by cell signaling kinases 2025 ·Science ·(unknown),Meritxell B. Cutrona,Wojciech Rosikiewicz,(unknown),Patrick Fernandes Rodrigues,John J. Bowling,(unknown),Walter H. Lang,(unknown),(unknown),Beisi Xu,Shondra M. Pruett‐Miller,Gang Wu,Taosheng Chen,Aseem Z. Ansari	0
3	Chemical manipulation of an activation/inhibition switch in the nuclear receptor PXR 2024 ·Nature Communications ·(unknown),Andrew D. Huber,Sergio C. Chai,Stanley Nithianantham,Yongtao Li,Jing Wu,(unknown),Darcie J. Miller,J. Seetharaman,Taosheng Chen	13
4	Ligand flexibility and binding pocket malleability cooperate to allow selective PXR activation by analogs of a promiscuous nuclear receptor ligand 2023 ·Structure ·Andrew D. Huber,(unknown),Yongtao Li,Wenwei Lin,Jing Wu,Darcie J. Miller,Taosheng Chen	9
5	Fragment-Based NMR Screening of the BPTF PHD Finger Methyl Lysine Reader Leads to the First Small-Molecule Inhibitors 2023 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Sourav Das,Clifford T. Gee,(unknown),Sergio C. Chai,Richard Lee,Taosheng Chen,Daniel A. Harki,Anang A. Shelat,William C. K. Pomerantz	2
6	Small molecule SJ572946 activates BAK to initiate apoptosis 2022 ·iScience ·G. Sekar,(unknown),Xingping Qin,Cristina D. Guibao,(unknown),Zintis Inde,Christy R. Grace,Weixing Zhang,P.J. Slavish,Wenwei Lin,Taosheng Chen,Richard Lee,Zoran Ranković,Kristopher A. Sarosiek,Tudor Moldoveanu	9
7	Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader 2022 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Wenwei Lin,Elizabeth C. Griffith,Richard Lee,Taosheng Chen,Daniel A. Harki,William C. K. Pomerantz	8
8	Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation 2021 ·Clinical Cancer Research ·(unknown),Mingqing Chen,(unknown),Alice A. Gibson,(unknown),Shichen Shen,Jun Qu,Su Sien Ong,Taosheng Chen,Yan Jin,Muhammad Erfan Uddin,Kevin M. Huang,Aviv Paz,Alex Sparreboom,Shuiying Hu,Jason A. Sprowl	27
9	BRAF inhibition protects against hearing loss in mice 2020 ·Science Advances ·Matthew A. Ingersoll,(unknown),(unknown),(unknown),Zhenhang Xu,Marisa Zallocchi,Duane Currier,Huizhan Liu,David Z. Z. He,Jaeki Min,Taosheng Chen,Jian Zuo,Tal Teitz	40
10	Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen 2020 ·eLife ·Hao Zhang,Yang Zhang,Xinyue Zhou,Shaela Wright,Judith Hyle,Lianzhong Zhao,Jie An,Xujie Zhao,Ying Shao,Beisi Xu,Hyeong-Min Lee,Taosheng Chen,Yang Zhou,Xiang Chen,Rui Lu,Chunliang Li	27
11	Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5 2020 ·Journal of Medicinal Chemistry ·William C. Wright,(unknown),Jingheng Wang,Hazel M. Girvan,Lei Yang,Sergio C. Chai,Andrew D. Huber,Jing Wu,Peter Oladimeji,Andrew W. Munro,Taosheng Chen	34
12	MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation 2020 ·Cell Death Discovery ·(unknown),(unknown),(unknown),Zhenya Hong,Gamze B. Bulut,Wei Zhuang,Sadie Miki Sakurada,Jamshid Temirov,Jonathan Low,Taosheng Chen,Shondra M. Pruett‐Miller,Lily Huang,Malia B. Potts	6
13	Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 ⁺ T cell responses 2019 ·Science Translational Medicine ·Anthony E. Zamora,Jeremy Chase Crawford,E. Kaitlynn Allen,Xi-zhi J. Guo,Jesse Bakke,Robert Carter,Hossam A. Abdelsamed,Ardiana Moustaki,Yongjin Li,Ti‐Cheng Chang,Walid Awad,Mari Dallas,Charles G. Mullighan,James R. Downing,Terrence L. Geiger,Taosheng Chen,Douglas R. Green,Ben Youngblood,Jinghui Zhang,Paul G. Thomas	59
14	High-Throughput Screening Identifies 1,4,5-Substituted 1,2,3-Triazole Analogs as Potent and Specific Antagonists of Pregnane X Receptor 2017 ·Assay and Drug Development Technologies ·Wenwei Lin,Asli N. Goktug,Jing Wu,Duane Currier,Taosheng Chen	12
15	An unexpected protein interaction promotes drug resistance in leukemia 2017 ·Nature Communications ·Aaron Pitre,Yubin Ge,Wenwei Lin,Yao Wang,Yu Fukuda,Jamshid Temirov,Aaron H. Phillips,Jennifer L. Peters,Yiping Fan,Jing Ma,Amanda Nourse,Chandrima Sinha,Hai Lin,Richard W. Kriwacki,James R. Downing,Tanja A. Grüber,Victoria E. Centonze,Anjaparavanda P. Naren,Taosheng Chen,John D. Schuetz	20
16	Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death 2016 ·Cancer Research ·Eric I. Zimmerman,Alice A. Gibson,Shuiying Hu,Aksana Vasilyeva,Shelley Orwick,Guoqing Du,(unknown),Su Sien Ong,Taosheng Chen,Peter Vogel,Hiroto Inaba,Michael L. Maitland,Alex Sparreboom,Sharyn D. Baker	38
17	High Throughput Screening Identified a Substituted Imidazole as a Novel RANK Pathway-Selective Osteoclastogenesis Inhibitor 2006 ·Assay and Drug Development Technologies ·Taosheng Chen,A C Knapp,Wu Yang,Jinwen Huang,Jean S. Lynch,John K. Dickson,R. Michael Lawrence,Jean H.M. Feyen,(unknown)	10
18	Cell-Based Assay Strategy for Identification of Motif-Specific RANK Signaling Pathway Inhibitors 2006 ·Assay and Drug Development Technologies ·Taosheng Chen,Xu Feng	6
19	Analysis of cellular events using CellCard™ System in cell-based high-content multiplexed assays 2005 ·Expert Review of Molecular Diagnostics ·Taosheng Chen,George P. Hansen,(unknown),Kristin Yates,Yingjie Zhu,(unknown),(unknown),Martyn Banks	3
20	Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. 2000 ·PubMed ·Taosheng Chen,Lihua Wang,William L. Farrar	214

About Taosheng Chen

Taosheng Chen is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 154 papers that have together received 5.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (59 papers), Hormonal Regulation and Hypertension (36 papers) and Estrogen and related hormone effects (30 papers). The work is most often cited by research in Pharmacology (1.4k citations), Oncology (1.3k citations) and Endocrinology, Diabetes and Metabolism (803 citations). Taosheng Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Wenwei Lin, Sergio C. Chai, William L. Farrar, Lihua Wang, Yueming Wang, Peter Oladimeji, Su Sien Ong, Jing Wu, William C. Wright and Jing Wu. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact